Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 243 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Kountouras, Jannis [Clear All Filters]
Potential molecular aspects of Helicobacter pylori-related hyperplastic polyp development and progression..
Eur J Gastroenterol Hepatol. 28(7), 851-2.
(2016).
(2016). Active Infection Is a Risk Factor for Colorectal Mucosa: Early and Advanced Colonic Neoplasm Sequence..
Gut Liver. 11(5), 733-734.
(2017). Adipose tissue, obesity and non-alcoholic fatty liver disease..
Minerva Endocrinol. 42(2), 92-108.
(2017). Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy..
Int J Cardiol. 229, 17-18.
(2017). Comment on "Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics"..
World J Gastroenterol. 23(33), 6194-6196.
(2017). Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial..
Diabetes Obes Metab. 19(12), 1805-1809.
(2017). A fully covered self-expandable metal stent anchored by a 10-Fr double pigtail plastic stent: an effective anti-migration technique..
Ann Gastroenterol. 30(1), 114-117.
(2017). Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?.
Int J Cardiol. 233, 92.
(2017). Helicobacter pylori on portal hypertension-related hepatic encephalopathy..
Immunopharmacol Immunotoxicol. 39(2), 105-106.
(2017). Helicobacter pylori-related chronic hepatitis C infection and the risk for cardiovascular disease..
Liver Int. 37(7), 1082.
(2017). Helicobacter pylori-related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett's esophagus cohort..
Gastrointest Endosc. 85(2), 462-463.
(2017). Impact of nitroglycerin and glucagon administration on selective common bile duct cannulation and prevention of post-ERCP pancreatitis..
Scand J Gastroenterol. 52(1), 50-55.
(2017). Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis..
Free Radic Res. 51(1), 73-79.
(2017). Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists..
Metabolism. 66, 64-68.
(2017). Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system..
Med Hypotheses. 102, 33-36.
(2017). Obesity and the nervous system: more questions..
Lancet Neurol. 16(10), 772-773.
(2017). A potential impact of Helicobacter pylori infection on both obstructive sleep apnea and atrial fibrillation-related stroke..
Sleep Med. 34, 256.
(2017).
(2017).
(2017). Comment on "Therapeutic Application of an Extract of Ameliorates the Development of Allergic Airway Disease"..
J Immunol. 200(9), 3027.
(2018). Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence..
Am J Gastroenterol. 113(11), 1723-1724.
(2018). The impact of age on the incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis..
Ann Gastroenterol. 31(1), 96-101.
(2018). Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on gastroesophageal reflux disease- Barrett's esophagus- esophageal adenocarcinoma sequence..
Helicobacter. 23(6), e12534.
(2018). infection and esophageal adenocarcinoma: a review and a personal view..
Ann Gastroenterol. 31(1), 8-13.
(2018).